共 50 条
- [1] Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials A Position Statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association CIRCULATION, 2009, 119 (02) : 351 - 357
- [2] Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials A position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association DIABETES CARE, 2009, 32 (01) : 187 - 192
- [3] Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials A Position Statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (03) : 298 - 304
- [4] Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials: A Position Statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association (vol 119, pg 351, 2009) CIRCULATION, 2009, 119 (25) : E605 - E605
- [5] Aspirin for Primary Prevention of Cardiovascular Events in People With Diabetes A Position Statement of the American Diabetes Association, a Scientific Statement of the American Heart Association, and an Expert Consensus Document of the American College of Cardiology Foundation CIRCULATION, 2010, 121 (24) : 2694 - 2701
- [6] Aspirin for Primary Prevention of Cardiovascular Events in People With Diabetes A position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation DIABETES CARE, 2010, 33 (06) : 1395 - 1402
- [7] Aspirin for Primary Prevention of Cardiovascular Events in People With Diabetes A Position Statement of the American Diabetes Association, a Scientific Statement of the American Heart Association, and an Expert Consensus Document of the American College of Cardiology Foundation JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (25) : 2878 - 2886
- [8] Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation (vol 33, pg 1395, 2010) DIABETES CARE, 2010, 33 (09) : 2129 - 2131
- [9] Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation (vol 33, pg 1395, 2010) DIABETES CARE, 2011, 34 (01) : 247 - 248